Compositions and methods for inhibiting NF-κB and SOD-1 to treat amyotrophic lateral sclerosis (U.S. Patent Number 9,725,719)

The invention relates to the pharmaceutical compositions, kits, methods, and uses for the treatment of amyotrophic lateral sclerosis. In particular, the invention relates to the pharmaceutical compositions, kits, methods to inhibit NF-κB in microglia or macrophages which will delay motor neuron death.